Scientists
Enhanced Cytotoxicity of DNA Topoisomerase II Inhibitor Compound C-1305 Toward HeLa Cells
Research from Poland has revealed that the DNA topoisomerase II inhibitor compound C-1305 exhibits increased cytotoxicity toward HeLa cells when PARP-1 activity is downregulated. The study, published in Biochemical Pharmacology, found that the combination of C-1305 and PARP-1 inhibitor NU1025 led to synergistic cytotoxic effects toward tumor cells. The researchers